H-LVVVGAGGVGK^-OH

Ref. 3D-PP48409

Informação sobre produto

• Nome: H-LVVVGAGGVGK^-OH

Descrição

Peptide H-LVVVGAGGVGK^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LVVVGAGGVGK^-OH include the following: Comprehensive detection of single amino acid variants and evaluation of their deleterious potential in a PANC-1 cell line Z Tan, J Zhu, PM Stemmer , L Sun, Z Yang - Journal of proteome , 2020 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.9b00840 Targeted data-independent acquisition for mass spectrometric detection of RAS mutations in formalin-fixed, paraffin-embedded tumor biopsies YJ Kim, AG Chambers, F Cecchi, T Hembrough - Journal of Proteomics, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1874391918301829 Facile carrier-assisted targeted mass spectrometric approach for proteomic analysis of low numbers of mammalian cells T Shi , MJ Gaffrey, TL Fillmore, CD Nicora , L Yi - Communications , 2018 - nature.comhttps://www.nature.com/articles/s42003-018-0107-6 Peptidoform analysis of IP-MS data allows detection of differentially present bait proteoforms S Sdelci, S Sdelci, S Kourtis, D Cianferoni , L Serrano - bioRxiv, 2024 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2024.01.23.576810.abstract Detection of differential bait proteoforms through immunoprecipitation-mass spectrometry data analysis S Kourtis, D Cianferoni , L Serrano, S Sdelci - Scientific Data, 2024 - nature.comhttps://www.nature.com/articles/s41597-024-03394-x The measurement of KRAS G12 mutants using multiplexed selected reaction monitoring and ion mobility mass spectrometry RL Norman, R Singh, JI Langridge - Rapid , 2020 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.8657 Mutant proteins as cancer-specific biomarkers Q Wang , R Chaerkady , J Wu - Proceedings of the , 2011 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1019203108 Selected reaction monitoring approach for validating peptide biomarkers Q Wang , M Zhang , T Tomita - Proceedings of the , 2017 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1712731114 THE CLINICAL PROTEOMICS OF CANCER Q Wang - 2014 - jscholarship.library.jhu.eduhttps://jscholarship.library.jhu.edu/bitstream/1774.2/59387/1/WANG-DISSERTATION-2015.pdf GeLC-MRM quantitation of mutant KRAS oncoprotein in complex biological samples PJ Halvey, CR Ferrone , DC Liebler - Journal of proteome research, 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/pr300161j Carrier-assisted single-tube processing approach for targeted proteomics analysis of low numbers of mammalian cells P Zhang , MJ Gaffrey, Y Zhu , WB Chrisler - Analytical , 2018 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.8b04258 A complete search of combinatorial peptide library greatly benefited from probabilistic incorporation of prior knowledge M Hruska, D Holub - International Journal of Mass Spectrometry, 2022 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1387380621002049 Identification of variant peptides using mass spectrometry M Hruška - theses.czhttps://theses.cz/id/1glpu2/Thesis.pdf Author Paper of Dissertation thesis M Hruška - theses.czhttps://theses.cz/id/1glpu2/Author-paper_Archive.pdf Fragment Optimization of Reversible Binding to the Switch II Pocket on KRAS Leads to a Potent, In Vivo Active KRASG12C Inhibitor J Bröker, AG Waterson , C Smethurst - Journal of Medicinal , 2022 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.2c01120 An improved quantitative mass spectrometry analysis of tumor specific mutant proteins at high sensitivity I Ruppen-Caaca±as , PP Lopez-Casas , F Garcaca­a - , 2012 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201100611 Applications of targeted proteomics in systems biology and translational medicine HA Ebhardt , A Root , C Sander , R Aebersold - Proteomics, 2015 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/pmic.201500004 Absolute quantification of endogenous Ras isoform abundance CJ Mageean, JR Griffiths , DL Smith, MJ Clague - PLoS , 2015 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0142674 Proteogenomics of colorectal cancer liver metastases: complementing precision oncology with phenotypic data B Blank-Landeshammer , VR Richard , G Mitsa - Cancers, 2019 - mdpi.comhttps://www.mdpi.com/2072-6694/11/12/1907 CRAF dimerization with ARAF regulates KRAS-driven tumor growth A Venkatanarayan , J Liang, I Yen, F Shanahan - Cell reports, 2022 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(22)00067-5.pdf Detection and verification of 2.3 million cancer mutations in NCI60 cancer cell lines with a cloud search engine A Prakash, S Majumder, S Ahmad, M Varkey - Journal of , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S187439191930260X Screening protein isoforms predictive for cancer using immunoaffinity capture and fast LC-MS in PRM mode A Lesur , L Ancheva, YJ Kim, G Berchem - PROTEOMICS , 2015 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.201400158 Non-clinical identification and characterization of KRAS G12D inhibitors A Brooun, JH Bae, H Chen, P Li, B Lin - European Journal of , 2022 - erasca.comhttps://www.erasca.com/wp-content/uploads/2022/10/Triple_ERAS-4_poster__FINAL.pdf The pharmacologic and toxicologic characterization of the potent and selective KRAS G12D inhibitors ERAS-4693 and ERAS-5024 A Brooun, J Zhang, C Li, R Lam, H Cheng - Toxicology and Applied , 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0041008X23002405

• Marca: Biosynth